Članki z zahtevami za javni dostop - Daniel GaudetVeč o tem
Ni na voljo nikjer: 23
Rarity of anti–3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase antibodies in statin users, including those with self‐limited musculoskeletal side effects
AL Mammen, K Pak, EK Williams, D Brisson, J Coresh, E Selvin, ...
Arthritis care & research 64 (2), 269-272, 2012
Zahteve: US National Institutes of Health, Canadian Institutes of Health Research
Squalene synthase: a critical enzyme in the cholesterol biosynthesis pathway
R Do, RS Kiss, D Gaudet, JC Engert
Clinical genetics 75 (1), 19-29, 2009
Zahteve: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé
Review of the clinical development of alipogene tiparvovec gene therapy for lipoprotein lipase deficiency
D Gaudet, J de Wal, K Tremblay, S Déry, S van Deventer, A Freidig, ...
Atherosclerosis Supplements 11 (1), 55-60, 2010
Zahteve: Canadian Institutes of Health Research
DNA methylation variations at CETP and LPL gene promoter loci: new molecular biomarkers associated with blood lipid profile variability
SP Guay, D Brisson, B Lamarche, P Marceau, MC Vohl, D Gaudet, ...
Atherosclerosis 228 (2), 413-420, 2013
Zahteve: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé
Etiology and risk of lactescent plasma and severe hypertriglyceridemia
K Tremblay, J Méthot, D Brisson, D Gaudet
Journal of clinical lipidology 5 (1), 37-44, 2011
Zahteve: Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada
Cardiovascular disease in familial hypercholesterolemia: validation and refinement of the Montreal-FH-SCORE
M Paquette, D Brisson, R Dufour, É Khoury, D Gaudet, A Baass
Journal of clinical lipidology 11 (5), 1161-1167. e3, 2017
Zahteve: Canadian Institutes of Health Research, Leducq Foundation, USA
Epigenome-wide analysis in familial hypercholesterolemia identified new loci associated with high-density lipoprotein cholesterol concentration
SP Guay, G Voisin, D Brisson, J Munger, B Lamarche, D Gaudet, ...
Epigenomics 4 (6), 623-639, 2012
Zahteve: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé
Epigenetic dysregulation of the IGF system in placenta of newborns exposed to maternal impaired glucose tolerance
V Desgagne, MF Hivert, J St-Pierre, SP Guay, JP Baillargeon, P Perron, ...
Epigenomics 6 (2), 193-207, 2014
Zahteve: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé
LRP1B, BRD2 and CACNA1D: New Candidate Genes in Fetal Metabolic Programming of Newborns Exposed to Maternal Hyperglycemia
AA Houde, SM Ruchat, C Allard, JP Baillargeon, J St-Pierre, P Perron, ...
Epigenomics 7 (7), 1111-1122, 2015
Zahteve: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé
Epigenetic and Genetic Variations at the TNNT1 Gene Locus are Associated with HDL-C Levels and Coronary Artery Disease
SP Guay, C Légaré, D Brisson, P Mathieu, Y Bossé, D Gaudet, ...
Epigenomics 8 (3), 359-371, 2016
Zahteve: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé …
Comparison of the efficacy of fibrates on hypertriglyceridemic phenotypes with different genetic and clinical characteristics
D Brisson, J Méthot, K Tremblay, M Tremblay, P Perron, D Gaudet
Pharmacogenetics and genomics 20 (12), 742-747, 2010
Zahteve: Canadian Institutes of Health Research
A study in familial hypercholesterolemia suggests reduced methylomic plasticity in men with coronary artery disease
SP Guay, D Brisson, P Mathieu, Y Bossé, D Gaudet, L Bouchard
Epigenomics 7 (1), 17-34, 2015
Zahteve: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé
Lomitapide for treatment of homozygous familial hypercholesterolemia: the Québec experience
S Aljenedil, L Alothman, AM Bélanger, L Brown, Z Lahijanian, J Bergeron, ...
Atherosclerosis 310, 54-63, 2020
Zahteve: Canadian Institutes of Health Research, Leducq Foundation, USA
On-site management of investigational products and drug delivery systems in conformity with Good Clinical Practices (GCPs)
J Méthot, D Brisson, D Gaudet
Clinical trials 9 (2), 265-271, 2012
Zahteve: Canadian Institutes of Health Research
DNA methylation at LRP1 gene locus mediates the association between maternal total cholesterol changes in pregnancy and cord blood leptin levels
SP Guay, AA Houde, E Breton, JP Baillargeon, P Perron, D Gaudet, ...
Journal of Developmental Origins of Health and Disease 11 (4), 369-378, 2020
Zahteve: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé
A locus on chromosome 10 influences C-reactive protein levels in two independent populations
U Broeckel, C Hengstenberg, B Mayer, K Maresso, D Gaudet, O Seda, ...
Human genetics 122, 95-102, 2007
Zahteve: German Research Foundation
The g.-469G> A polymorphism in the GPIHBP1 gene promoter is associated with hypertriglyceridemia and has an additive effect on the risk conferred by LPL defective alleles
SP Guay, D Gaudet, D Brisson
Nutrition, Metabolism and Cardiovascular Diseases 23 (4), 358-365, 2013
Zahteve: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé
Contribution of adiponectin to the cardiometabolic risk of postmenopausal women with loss-of-function lipoprotein lipase gene mutations
Y Loucif, J Méthot, K Tremblay, D Brisson, D Gaudet
Menopause 18 (5), 558-562, 2011
Zahteve: Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada
Long-term efficacy and safety of lomitapide for the treatment of homozygous familial hypercholesterolemia: Results of the phase 3 extension trial
D Blom, M Averna, E Meagher, H Theron, C Sirtori, R Hegele, P Shah, ...
Journal of Clinical Lipidology 10 (3), 708-710, 2016
Zahteve: American Heart Association
Visceral fat enhances blood pressure reactivity to physical but not mental challenges in male adolescents
M Van Woudenberg, M Abrahamowicz, G Leonard, M Perron, L Richer, ...
Pediatric Obesity 10 (5), 395-402, 2015
Zahteve: Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada
Podatke o objavi in financiranju samodejno določi računalniški program